{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:06:58Z","timestamp":1792048018210,"version":"4.4.0"},"reference-count":29,"publisher":"American Chemical Society (ACS)","issue":"30","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["24JCQNJC01050"],"award-info":[{"award-number":["24JCQNJC01050"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Scientific and Technological Talents in Tianjin","award":["QN20230333"],"award-info":[{"award-number":["QN20230333"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Carrier-free nanomedicines offer a promising strategy to simplify formulation while maximizing therapeutic function. Here, we report a disulfide-containing self-assembling peptide, Fmoc-Cys(StBu)-Phe-Phe-Tyr-Lys-Cys(StBu) (Fmoc-S-S), as a minimalist nanomedicine for dual redox cancer therapy. Fmoc-S-S spontaneously formed uniform spherical nanoparticles with favorable hemocompatibility, glutathione-responsive structural transformation, and enhanced tumor accumulation in vivo. Mechanistically, Fmoc-S-S disrupted intracellular redox homeostasis by depleting glutathione, altering the NADP+\/NADPH balance, suppressing SLC7A11 and GPX4, promoting lipid peroxidation, and reducing mitochondrial membrane potential, consistent with ferroptosis induction. Meanwhile, biochemical evidence of intracellular disulfide stress, including decreased cysteine levels, together with partial rescue by dithiothreitol and marked F-actin disruption, supported the involvement of disulfidptosis. In MC38 tumor-bearing mice, Fmoc-S-S nanoparticles significantly inhibited tumor growth without obvious systemic toxicity. Proteomic analysis further revealed coordinated dysregulation of pathways associated with glutathione metabolism, mitochondrial function, oxidative phosphorylation, and cytoskeletal organization. Together, this work presents a self-assembled peptide biomaterial that integrates nanostructure formation, tumor delivery, and dual induction of ferroptosis and disulfidptosis within a single carrier-free system, providing a new strategy for redox-directed cancer therapy.<\/jats:p>","DOI":"10.1021\/acsami.6c08792","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:09:44Z","timestamp":1784653784000},"page":"40372-40382","source":"Crossref","is-referenced-by-count":2,"title":["A Carrier-Free Peptide Nanomedicine Orchestrates Dual Redox Therapy via Ferroptosis and Disulfidptosis"],"prefix":"10.1021","volume":"18","author":[{"given":"Yuting","family":"Kong","sequence":"first","affiliation":[{"name":"Tianjin Medical University , , ,","place":["Tianjin, China, 300070"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Peng","sequence":"additional","affiliation":[{"name":"Tianjin Medical University , , ,","place":["Tianjin, China, 300070"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liang","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Yan","sequence":"additional","affiliation":[{"name":"Tianjin Medical University , , ,","place":["Tianjin, China, 300070"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Tianjin Medical University , , ,","place":["Tianjin, China, 300070"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2367-4433","authenticated-orcid":true,"given":"Gongyu","family":"Li","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6791-323X","authenticated-orcid":true,"given":"Zhen","family":"Zheng","sequence":"additional","affiliation":[{"name":"Tianjin Medical University , , ,","place":["Tianjin, China, 300070"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"7","key":"2026080518082687000_cit1","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2017.24","article-title":"Rethinking Cancer Nanotheranostics","volume":"2","author":"Chen","year":"2017","journal-title":"Nat. Rev. Mater."},{"issue":"6","key":"2026080518082687000_cit2","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1039\/D5RA08728G","article-title":"Engineering Combination Nanomedicines to Overcome Cancer Resistance","volume":"16","author":"Singh","year":"2026","journal-title":"RSC Adv."},{"key":"2026080518082687000_cit3","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2025.1002355","article-title":"Next-Generation Nanocarriers for Precision Antitumor Therapy: From Passive Targeting to Intelligent Response","volume":"6","author":"Singh","year":"2025","journal-title":"Explor. Target. Antitumor Ther."},{"key":"2026080518082687000_cit4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jconrel.2020.10.014","article-title":"Carrier-Free Nanodrugs for Safe and Effective Cancer Treatment","volume":"329","author":"Karaosmanoglu","year":"2021","journal-title":"J. Controlled Release"},{"issue":"1","key":"2026080518082687000_cit5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.apsb.2021.08.012","article-title":"Pure Drug Nano-Assemblies: A Facile Carrier-Free Nanoplatform for Efficient Cancer Therapy","volume":"12","author":"Fu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"2026080518082687000_cit6","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202202307","article-title":"Recent Progress in Carrier-Free Nanomedicine for Tumor Phototherapy","volume":"12","author":"Zhong","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"23","key":"2026080518082687000_cit7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312662","article-title":"Self-Assembling Peptides: From Design to Biomedical Applications","volume":"22","author":"La Manna","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"2026080518082687000_cit8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1021\/acsabm.2c01041","article-title":"Self-Assembly, Bioactivity, and Nanomaterials Applications of Peptide Conjugates with Bulky Aromatic Terminal Groups","volume":"6","author":"Hamley","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"key":"2026080518082687000_cit9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jcis.2022.10.032","article-title":"CuxO Nanorod Arrays Shelled with CoNi Layered Double Hydroxide Nanosheets for Enhanced Oxygen Evolution Reaction under Alkaline Conditions","volume":"630","author":"Cai","year":"2023","journal-title":"J. Colloid Interface Sci."},{"issue":"43","key":"2026080518082687000_cit10","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq2072","article-title":"Engineering Supramolecular Peptide Nanofibers for in Vivo Platelet-Hitchhiking beyond Ligand-Receptor Recognition","volume":"10","author":"Feng","year":"2024","journal-title":"Sci. Adv."},{"issue":"2","key":"2026080518082687000_cit11","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020482","article-title":"Advances in Self-Assembled Peptides as Drug Carriers","volume":"15","author":"Gao","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026080518082687000_cit12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102374","article-title":"A Molecularly Tailored Closed-Loop Tumor Cell Energy Nanodepleter for Cancer Starvation Therapy","volume":"57","author":"Sun","year":"2024","journal-title":"Nano Today"},{"issue":"30","key":"2026080518082687000_cit13","doi-asserted-by":"publisher","first-page":"26557","DOI":"10.1021\/jacs.5c06533","article-title":"An Anaerobic Biomimetic Metal-Free AIE Polymersome Nanozyme as NADH Oxidase Mimic for Photocatalytic Tumor Suppression by Impairing Cancer Cell Energy Metabolism under Hypoxia","volume":"147","author":"Ma","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"2026080518082687000_cit14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine Transporter SLC7A11\/xCT in Cancer: Ferroptosis, Nutrient Dependency, and Cancer Therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"3","key":"2026080518082687000_cit15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin Cytoskeleton Vulnerability to Disulfide Stress Mediates Disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"2026080518082687000_cit16","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"5","key":"2026080518082687000_cit17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04923-5","article-title":"Programmed Cell Death in Atherosclerosis and Vascular Calcification","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"2026080518082687000_cit18","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/acsnano.4c15932","article-title":"Enhancing Ferroptosis-Mediated Radiosensitization via Synergistic Disulfidptosis Induction","volume":"19","author":"Li","year":"2025","journal-title":"ACS Nano"},{"key":"2026080518082687000_cit19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.bioactmat.2025.09.003","article-title":"Regulating SLC7A11\/GSH\/GPX4 Axis by Glucose Dyshomeostasis to Simultaneously Promote Disulfidptosis, Cuproptosis and Ferroptosis","volume":"54","author":"Zhang","year":"2025","journal-title":"Bioact. Mater."},{"issue":"14","key":"2026080518082687000_cit20","doi-asserted-by":"publisher","first-page":"14233","DOI":"10.1021\/acsnano.5c00730","article-title":"Synchronously Evoking Disulfidptosis and Ferroptosis via Systematical Glucose Deprivation Targeting SLC7A11\/GSH\/GPX4 Antioxidant Axis","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"key":"2026080518082687000_cit21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118499","article-title":"The Molecular Mechanisms of Disulfidptosis and Its Role in Diabetes Mellitus and Its Complications","volume":"191","author":"Zhang","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"2026080518082687000_cit22","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14010228","article-title":"The Mechanism and Regulation of Disulfidptosis and Its Role in Disease","volume":"14","author":"Wan","year":"2026","journal-title":"Biomedicines"},{"issue":"1","key":"2026080518082687000_cit23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13046-023-02712-2","article-title":"Disulfidptosis: A New Form of Programmed Cell Death","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2026080518082687000_cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.115094","article-title":"Nanomedicine Strategies for Disulfidptosis Activation in SLC7A11-High Tumors","volume":"257","author":"Ye","year":"2026","journal-title":"Colloids Surf., B"},{"key":"2026080518082687000_cit25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jare.2025.03.052","article-title":"Exploiting Metabolic Vulnerabilities through Synergistic Ferroptosis and Disulfidptosis for Breast Cancer Therapy","volume":"79","author":"Liang","year":"2026","journal-title":"J. Adv. Res."},{"issue":"41","key":"2026080518082687000_cit26","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202301600","article-title":"A Self-Assembly Nano-Prodrug for Combination Therapy in Triple-Negative Breast Cancer Stem Cells","volume":"19","author":"Wu","year":"2023","journal-title":"Small"},{"key":"2026080518082687000_cit27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.153595","article-title":"Albumin Tailoring Molecular Rotation and Electrophilicity of a GSH-Depleting Radiosensitizer for Potentiating Ferroptosis-Mediated Radioimmunotherapy","volume":"495","author":"Gao","year":"2024","journal-title":"Chem. Eng. J."},{"key":"2026080518082687000_cit28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid Peroxidation and Ferroptosis: The Role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radical Biol. Med."},{"issue":"1","key":"2026080518082687000_cit29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","article-title":"Amino Acid Transporter SLC7A11\/xCT at the Crossroads of Regulating Redox Homeostasis and Nutrient Dependency of Cancer","volume":"38","author":"Koppula","year":"2018","journal-title":"Cancer Commun."}],"container-title":["ACS Applied Materials &amp; Interfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsami.6c08792","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aamick\/article-pdf\/18\/30\/40372\/66069823\/am-2026-08792z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aamick\/article-pdf\/18\/30\/40372\/66069823\/am-2026-08792z.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:25:09Z","timestamp":1785968709000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aamick\/article\/18\/30\/40372\/5222707\/A-Carrier-Free-Peptide-Nanomedicine-Orchestrates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":29,"journal-issue":{"issue":"30","published-online":{"date-parts":[[2026,7,21]]},"published-print":{"date-parts":[[2026,8,5]]}},"URL":"https:\/\/doi.org\/10.1021\/acsami.6c08792","relation":{},"ISSN":["1944-8244","1944-8252"],"issn-type":[{"value":"1944-8244","type":"print"},{"value":"1944-8252","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}